China Medicine Corporation
Symbol: CHME
PNK
0.028
USDMarket price today
0.0009
P/E Ratio
-0.0001
PEG Ratio
79.67M
MRK Cap
- 0.00%
DIV Yield
China Medicine Corporation (CHME) Financial Statements
Balance Sheet
common:word.in-mln USD Growth | TTM | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 0.5 | 2.8 | 5.8 | ||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.net-receivables | 0 | 22.3 | 19.8 | 13.6 | ||||||
balance-sheet.row.inventory | 0 | 2.7 | 4.7 | 3.9 | ||||||
balance-sheet.row.other-current-assets | 0 | 0.5 | 6.3 | 6.1 | ||||||
balance-sheet.row.total-current-assets | 0 | 30.3 | 33.7 | 29.4 | ||||||
balance-sheet.row.property-plant-equipment-net | 0 | 12 | 3.8 | 1.4 | ||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.intangible-assets | 0 | 16.7 | 1.2 | 1.2 | ||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 16.7 | 1.2 | 1.2 | ||||||
balance-sheet.row.long-term-investments | 0 | 7.9 | 0 | 0 | ||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.other-non-current-assets | 0 | 0 | 6 | 0.7 | ||||||
balance-sheet.row.total-non-current-assets | 0 | 36.6 | 11 | 3.2 | ||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.total-assets | 0 | 66.8 | 44.7 | 32.6 | ||||||
balance-sheet.row.account-payables | 0 | 1.3 | 0.1 | 0 | ||||||
balance-sheet.row.short-term-debt | 0 | 9.5 | 0 | 0 | ||||||
balance-sheet.row.tax-payables | 0 | 2.1 | 0.8 | 0 | ||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 0 | 0 | ||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||
balance-sheet.row.other-current-liab | 0 | 0.5 | 1 | 0.9 | ||||||
balance-sheet.row.total-non-current-liabilities | 0 | 6.9 | 0 | 0 | ||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.total-liab | 0 | 21.3 | 1.1 | 0.9 | ||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.common-stock | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.retained-earnings | 0 | 22.9 | 22.1 | 14 | ||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 4.4 | 4.4 | 4.3 | ||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 17.7 | 16.2 | 12.6 | ||||||
balance-sheet.row.total-stockholders-equity | 0 | 45 | 42.8 | 30.9 | ||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 66.8 | 44.7 | 32.6 | ||||||
balance-sheet.row.minority-interest | 0 | 0.5 | 0.8 | 0.9 | ||||||
balance-sheet.row.total-equity | 0 | 45.5 | 43.6 | 31.8 | ||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||
Total Investments | 0 | 7.9 | 0 | 0 | ||||||
balance-sheet.row.total-debt | 0 | 9.5 | 0 | 0 | ||||||
balance-sheet.row.net-debt | 0 | 9 | -2.8 | -5.8 |
Cash Flow Statement
common:word.in-mln USD Growth | TTM | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 1.4 | 9.1 | 6.9 | ||||||
cash-flows.row.depreciation-and-amortization | 0 | 1 | 0.4 | 0.8 | ||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.stock-based-compensation | 0 | 0.1 | 0.1 | 0 | ||||||
cash-flows.row.change-in-working-capital | 0 | 7.1 | -5.4 | -10.1 | ||||||
cash-flows.row.account-receivables | 0 | -2.3 | -4.8 | 0 | ||||||
cash-flows.row.inventory | 0 | 3.4 | -0.5 | -1.8 | ||||||
cash-flows.row.account-payables | 0 | 0.6 | 0 | 0 | ||||||
cash-flows.row.other-working-capital | 0 | 5.4 | -0.1 | -8.2 | ||||||
cash-flows.row.other-non-cash-items | 0 | 7.3 | -0.1 | 0.1 | ||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -3.7 | -2.7 | -0.4 | ||||||
cash-flows.row.acquisitions-net | 0 | -8 | 0 | 0 | ||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -5.2 | 0 | ||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.other-investing-activites | 0 | -1.9 | 0 | 0 | ||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -13.5 | -7.9 | -0.4 | ||||||
cash-flows.row.debt-repayment | 0 | -10.6 | 0 | 0 | ||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 7.8 | ||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.other-financing-activites | 0 | 4.9 | 0.4 | 0 | ||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -5.7 | 0.4 | 7.8 | ||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0.3 | 0.3 | ||||||
cash-flows.row.net-change-in-cash | 0 | -2.3 | -3 | 5.4 | ||||||
cash-flows.row.cash-at-end-of-period | 0 | 0.5 | 2.8 | 5.8 | ||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 2.8 | 5.8 | 0.4 | ||||||
cash-flows.row.operating-cash-flow | 0 | 17 | 4.2 | -2.3 | ||||||
cash-flows.row.capital-expenditure | 0 | -3.7 | -2.7 | -0.4 | ||||||
cash-flows.row.free-cash-flow | 0 | 13.3 | 1.5 | -2.7 |
Income Statement Row
common:word.in-mln USD Growth | TTM | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 64.8 | 53.6 | 42.1 | ||||||
income-statement-row.row.cost-of-revenue | 0 | 45.8 | 38.1 | 29.7 | ||||||
income-statement-row.row.gross-profit | 0 | 19 | 15.6 | 12.4 | ||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0 | ||||||
income-statement-row.row.operating-expenses | 0 | 6.7 | 4.6 | 4 | ||||||
income-statement-row.row.cost-and-expenses | 0 | 52.5 | 42.7 | 33.7 | ||||||
income-statement-row.row.interest-income | 0 | 0 | 0 | 0 | ||||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0 | ||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||
income-statement-row.row.total-other-income-expensenet | 0 | -7.3 | 0.1 | 0 | ||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0 | ||||||
income-statement-row.row.total-operating-expenses | 0 | -7.3 | 0.1 | 0 | ||||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0 | ||||||
income-statement-row.row.depreciation-and-amortization | 0 | 1 | 0.4 | 0.8 | ||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||
income-statement-row.row.operating-income | 0 | 12.3 | 10.9 | 8.4 | ||||||
income-statement-row.row.income-before-tax | 0 | 5 | 11 | 8.4 | ||||||
income-statement-row.row.income-tax-expense | 0 | 3.5 | 2 | 1.6 | ||||||
income-statement-row.row.net-income | 0 | 1.7 | 9.1 | 6.9 |
Frequently Asked Question
What is China Medicine Corporation (CHME) total assets?
China Medicine Corporation (CHME) total assets is 66844482.000.
What is enterprise annual revenue?
The annual revenue is N/A.
What is firm profit margin?
Firm profit margin is 0.293.
What is company free cash flow?
The free cash flow is 0.870.
What is enterprise net profit margin?
The net profit margin is 0.027.
What is firm total revenue?
The total revenue is 0.189.
What is China Medicine Corporation (CHME) net profit (net income)?
The net profit (net income) is 1717677.000.
What is firm total debt?
The total debt is 9506160.000.
What is operating expences number?
The operating expences are 6718099.000.
What is company cash figure?
Enretprise cash is 0.000.